Garralda, E., Schram, A. M., Bedard, P. L., Schwartz, G. K., Yuen, E., McNeely, S. C., Ribeiro, S., Cunningham, J., Wang, Y., Urunuela, A., Xu, X., & LoRusso, P. (2023). A Phase I Dose-Escalation Study of LY3405105, a Covalent Inhibitor of Cyclin-Dependent Kinase 7, Administered to Patients With Advanced Solid Tumors. The Oncologist, 29(1), e131–e140. https://doi.org/10.1093/oncolo/oyad215